Qiming Venture Partners
Venture capital fundPortfolio in China: 2 funded startups tracked by Uback, 2 of them in a ranking.
Portfolio on Uback2startups, 1 country
In a ranking2ranked by AI-estimated valuation
On the Radar0eligible, not ranked
Latest deal trackedApr 2026Oricell Therapeutics
Portfolio on Uback
Sorted by Uback rank, then Radar by last round| Company | Uback | Sector | Round backed | Valuation (AI) |
|---|---|---|---|---|
| Oricell Therapeutics | #6 Gene & cell therapies | Healthtech › Biotech › Gene & cell therapies | Pre-IPO round · USD 110M · Apr 2026 | Hundreds of M$ |
| WeDoctor | #6 Telemedicine | Healthtech › Access to care › Telemedicine | Equity round · USD 163M · Sep 2022 | Unicorn |
Only startups that meet Uback’s eligibility rules are shown. Amounts are round sizes, not the fund’s share. Rounds as reported by public sources.
By sector
Deals tracked per year
12022
02023
02024
02025
12026
Co-investors
Vivo Capital · Beijing Medical · Health Care Industry Investment Fund · HongShan · Hermitage Capital · CICCFH · AIA
Investors that joined the same rounds, as reported by public sources.
Sources. caproasia.com, chinaventure.com.cn, fiercebiotech.com, prnewswire.com, as cited on each company’s profile.
Last updated: Sep 2026Report a missing dealReport an error
Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction.